Clinical Trials Logo

Cardiometabolic Risk clinical trials

View clinical trials related to Cardiometabolic Risk.

Filter by:

NCT ID: NCT03839212 Completed - Clinical trials for Human Immunodeficiency Virus

The Happy Older Latinos Are Active (HOLA) Health Promotion Study in HIV-Infected Latino Men

HOLAHIV
Start date: October 1, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the feasibility of an intervention to prevent chronic diseases like diabetes, high blood pressure, and obesity in midlife and older Latino adults living with HIV. The investigators expect that the participant will be in this study for seven months. Participants will be interviewed and asked to take part in walking groups.

NCT ID: NCT03773900 Completed - Abdominal Obesity Clinical Trials

Characterization of Gut Microbiota Composition and Activity After a Daily Supplementation of 4.5 g/Day of ChitinGlucan Fibre During 3 Weeks in At-cardiometabolic Risk Volunteers

FITACHITIN
Start date: November 7, 2018
Phase: N/A
Study type: Interventional

The aim of this study is to demonstrate the beneficial effects on gut microbiota composition and activity of the diary intake of insoluble fiber (extract from Aspergillus Niger) for three weeks. The first studies about the fiber have shown a favorable gut microbiota modulation and an improvement of metabolic parameters like LDL cholesterol. In addition to fecal measurements, several biomarkers of colic fermentation will be assessed: expired gases, PolyUnsaturated Fatty Acid, Short Chain Fatty Acid (SCFA) after a rich-fiber breakfast (= 15 grams) and a nutritional challenge test at lunch. The gastrointestinal tolerance of fiber intake and the intestinal transit modification will be also followed during all the study.

NCT ID: NCT03731013 Recruiting - Clinical trials for Cardiometabolic Risk

Combining a Mediterranean Diet With Physical Activity to Address Cardiometabolic Risk

MEx
Start date: October 22, 2018
Phase: N/A
Study type: Interventional

There is little doubt scientifically that healthy eating, such as adhering to the Mediterranean diet (MedDiet) principles, is key for the prevention of cardiovascular disease (CVD). There is also convincing evidence for a strong inverse relationship between moderate intensity physical activity (PA) and mortality. Surprisingly, no study has yet formally documented how the combination of a MedDiet and regular PA improves cardiometabolic health in high-risk individuals. Why is this an important issue to address? On the one hand, a rigorous demonstration that the combination of a healthy diet and PA is better than the sum of each part in terms of cardiometabolic benefits will underpin the importance of advocating the combination of both modalities systematically to maximize health effects. Alternatively (and provocatively), results showing that healthy eating and PA have non-additive or non-synergistic effects will imply that one needs to adhere to only one of these two lifestyle modalities to maximizes cardiometabolic benefits. The overarching aim of this research is to test the hypothesis that consumption of a MedDiet combined with PA do act synergistically to improve cardiometabolic risk. The investigators hypothesize that healthy eating and PA act in synergy to reduce postprandial lipemia, a powerful independent risk factor for coronary heart disease.

NCT ID: NCT03274739 Completed - Childhood Obesity Clinical Trials

Maternal Diet, Body Mass Index Trajectories and Cardiometabolic Risk in Early Childhood

Start date: February 2004
Phase:
Study type: Observational

This study focused on evaluating the association between adherence to the Mediterranean diet during pregnancy and offspring longitudinal body mass index trajectories and cardiometabolic risk in early-childhood. This study is part of a secondary data analysis of the INMA (INfancia y Medio Ambiente-(Environment and Childhood)) Project.

NCT ID: NCT03257085 Completed - Clinical trials for Cardiometabolic Risk

CALIBER Phase 1: A Pilot Study in Normal-weight and Overweight Adults.

CALIBER
Start date: March 9, 2017
Phase: N/A
Study type: Interventional

Pilot study to compare the impact of following a low-carbohydrate, high-fat diet versus following a high-carbohydrates, moderate-fat diet (UK dietary guidelines) on cardiometabolic risk markers and associated behaviours in a normal-weight and overweight adult population.

NCT ID: NCT02599272 Completed - Clinical trials for Cardiometabolic Risk

Effects of Mixed Spices on Cardiometabolic Function - the PolySPice (PSP) Study

PSP
Start date: October 7, 2015
Phase: N/A
Study type: Interventional

The study will investigate whether having mixed spices rich in polyphenols can improve postprandial cardiometabolic response in healthy Chinese men.

NCT ID: NCT02146339 Completed - Clinical trials for Cardiometabolic Risk

Impact of Milk Polar Lipids on Lipids Digestion, Absorption and Metabolism

VALOBAB-D
Start date: April 2014
Phase: N/A
Study type: Interventional

Polar lipids have a specific chemical structure: they are an essential component of human cell membranes, play a major role in the nervous system and also influence the metabolic pathways including the cholesterol metabolism. Polar lipids are used in food-processing industry for their emulsification properties. The most famous emulsifier is soya lecithin but milk also naturally contains natural emulsifiers such as polar lipids. Milk polar lipids are rich in sphingomyelin and they may have beneficial effects on lipid metabolism in the context of metabolic diseases of nutritional origin. The purpose of this research is to study the variation of sphingomyelin content at the ileum's end after the consumption of different doses of milk polar lipids, and consequences on the intestinal absorption and metabolism of fatty acids and cholesterol. The subjects will be taking three different test meals varying by their milk polar lipids content. It is a bi-centric study with a centre in LYON (Centre de Recherche en Nutrition Humaine Rhône-Alpes) and CLERMONT-FERRAND (Centre de Recherche en Nutrition Humaine Auvergne).

NCT ID: NCT02099032 Completed - Clinical trials for Cardiometabolic Risk

Milk Polar Lipids Consumption, Lipid Metabolism, and Inflammation in Menopausal Women

VALOBAB-C
Start date: March 2014
Phase: N/A
Study type: Interventional

Polar lipids have a specific chemical structure: they are an essential component of human cell membranes, play a major role in the nervous system and also influence the metabolic pathways including the cholesterol metabolism. Polar lipids are used in food-processing industry for their emulsification properties. The most famous emulsifier is soya lecithin but milk also naturally contains natural emulsifiers such as polar lipids. The purpose of this research is to study plasma cholesterol variation after daily intake of milk polar lipids-fortified cheese products. The volunteers will have to consume 100 g of cheese product during four weeks instead of their usual cheese products. It is a bi-centric study with a centre in LYON (Centre de Recherche en Nutrition Humaine Rhône-Alpes) and CLERMONT-FERRAND (Centre de Recherche en Nutrition Humaine Auvergne).

NCT ID: NCT01467544 Completed - Clinical trials for Cardiovascular Disease

Reduce Cardiovascular Risk in Women Through Tai Chi Intervention

Start date: June 2011
Phase: N/A
Study type: Interventional

Tai chi intervention may lead to relaxation and could potentially reduce the risk of cardiovascular disease. This project entails a comprehensive and innovative approach for understanding, measuring, and potentially reducing cardiovascular risk in women. The goal of this area of research is to reduce cardiovascular risk and perhaps reduce illness and death.